UK
Uday Kumar Akula
About Uday Kumar Akula
Data last updated:
Uday Kumar Akula is a Director at Trimark Pharmaceuticals Private Limited (since 2023). The company operates in Trading. Trimark Pharmaceuticals Private Limited reported revenue of ₹91.6 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Trimark Pharmaceuticals Private Limited U74999TG2016PTC112866 | Director | 06 Apr 2023 | 2016 | ₹91.6 Lakh (FY 2024) | Active |
Board colleagues of Uday Kumar Akula
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pavan Kumar Dubba | 10099732 | Trimark Pharmaceuticals Private Limited | Director |
| Pranitha Kasarapu | 07651874 | Trimark Pharmaceuticals Private Limited | Director |
| Rajendraprasad Kasarapu | 07651873 | Trimark Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Uday Kumar Akula
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Uday Kumar Akula
Uday Kumar Akula currently holds 1 directorship: Trimark Pharmaceuticals Private Limited (Director, since 06 Apr 2023, revenue ₹91.6 Lakh (FY 2024)).
Uday Kumar Akula was first appointed on 06 Apr 2023 as Director at Trimark Pharmaceuticals Private Limited.
The current boards of Uday Kumar Akula's companies include Pavan Kumar Dubba (Trimark Pharmaceuticals Private Limited), Pranitha Kasarapu (Trimark Pharmaceuticals Private Limited), Rajendraprasad Kasarapu (Trimark Pharmaceuticals Private Limited).